Upregulation of vitamin D receptor levels by 1,25(OH)(2) vitamin D-3 in cultured human keratinocytes

被引:26
作者
Solvsten, H
Svendsen, ML
Fogh, K
Kragballe, K
机构
[1] Department of Dermatology, Marselisborg Hospital
关键词
1,25-dihydroxyvitamin D-3; vitamin D receptor; keratinocytes; vitamin D receptor mRNA; 1,25-DIHYDROXYVITAMIN-D3 RECEPTORS; OSTEOSARCOMA CELLS; SARCOMA CELLS; EXPRESSION; DIFFERENTIATION; CLONING; BINDING; SYSTEM;
D O I
10.1007/s004030050206
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The natural biologically active form of vitamin D-3, 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3), possesses antiproliferative, prodifferentiating and immunomodulatory properties. The actions of 1,25(OH),D, are mediated through the intracellular vitamin D receptor (VDR), and the level of VDR is believed to determine the cellular responsiveness to vitamin D-3. In the present study we examined the effects of 1,25(OH)(2)D-3 on the expression of VDR and its message in cultured human keratinocytes. Western analysis showed the mean VDR content to be higher in undifferentiated cultures (175 pg/mu g protein) than in differentiated cultures (90 pg/mu g protein). Incubation with 1,25(OH),D, induced an increase in the VDR in both undifferentiated and differentiated keratinocytes. The VDR increase was detectable after 2 h and maximal (approximately twofold stimulation) after 8 h. The 1,25(OH)(2)D-3-induced stimulation of VDR levels was dose dependent with a maximum at 10(-7) M. The VDR mRNA levels as determined by the ribonuclease protection assay showed a peak (50% stimulation) after approximately 2 h. Although this increase in VDR mRNA was not statistically significant, the results indicate that the ligand-induced upregulation of VDR involves increased transcription. The upregulation of VDR levels may increase the responsiveness to 1,25(OH)(2)D-3 and may, therefore, be an important mechanism for regulating the effects of 1,25(OH)(2)D-3 on keratinocyte proliferation and differentiation.
引用
收藏
页码:367 / 372
页数:6
相关论文
共 24 条
  • [1] CLONING AND EXPRESSION OF FULL-LENGTH CDNA-ENCODING HUMAN VITAMIN-D RECEPTOR
    BAKER, AR
    MCDONNELL, DP
    HUGHES, M
    CRISP, TM
    MANGELSDORF, DJ
    HAUSSLER, MR
    PIKE, JW
    SHINE, J
    OMALLEY, BW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (10) : 3294 - 3298
  • [2] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [3] HORMONAL RESPONSES TO 1,25-DIHYDROXYVITAMIN-D3 IN CULTURED MOUSE OSTEOBLAST-LIKE CELLS - MODULATION BY CHANGES IN RECEPTOR LEVEL
    CHEN, TL
    LI, JM
    VANYE, T
    CONE, CM
    FELDMAN, D
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1986, 126 (01) : 21 - 28
  • [4] CHEN TL, 1981, J BIOL CHEM, V256, P5561
  • [5] REGULATION OF 1,25-DIHYDROXYVITAMIN-D3 RECEPTORS BY VITAMIN-D ANALOGS IN CULTURED MAMMALIAN-CELLS
    COSTA, EM
    HIRST, MA
    FELDMAN, D
    [J]. ENDOCRINOLOGY, 1985, 117 (05) : 2203 - 2210
  • [6] DOKOH S, 1984, CANCER RES, V44, P2103
  • [7] DEMONSTRATION OF 1,25-DIHYDROXYVITAMIN-D3 RECEPTORS IN HUMAN-SKIN BIOPSIES
    FELDMAN, D
    CHEN, T
    HIRST, M
    COLSTON, K
    KARASEK, M
    CONE, C
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (06) : 1463 - 1465
  • [8] HANAFIN NM, 1994, IN VITRO CELL DEV-AN, V30A, P187
  • [9] HENRIKSEN LO, 1996, IN PRESS SKIN PHARM
  • [10] REGULATION OF 1,25(OH)2VITAMIN-D3 RECEPTOR CONTENT IN CULTURED LLC-PK1 KIDNEY-CELLS LIMITS HORMONAL RESPONSIVENESS
    HIRST, M
    FELDMAN, D
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 116 (01) : 121 - 127